BioMarin Pharmaceutical Inc. buy Wells Fargo & Company
Start price
25.04.24
/
50%
€77.00
Target price
25.04.25
€102.63
Performance (%)
-2.57%
Price
03.07.24
€75.02
Summary
This prediction is currently active. With a performance of -2.57%, the BUY prediction for BioMarin Pharmaceutical Inc. by Wells_Fargo___Compan is down slightly. This prediction currently runs until 25.04.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioMarin Pharmaceutical Inc. | -5.373% | -5.373% |
iShares Core DAX® | 1.395% | -0.696% |
iShares Nasdaq 100 | 2.287% | 7.501% |
iShares Nikkei 225® | 1.617% | 2.769% |
iShares S&P 500 | 0.659% | 4.280% |
Comments by Wells_Fargo___Compan for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at Wells Fargo & Company from $100.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.46
27.06.24
27.06.24
€107.36
27.06.25
27.06.25
-3.49%
03.07.24
03.07.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€80.32
15.11.23
15.11.23
€92.05
15.11.24
15.11.24
-6.60%
03.07.24
03.07.24